PYC — Physiomics Income Statement
0.000.00%
Last trade - 00:00- £1.29m
- £1.02m
- £0.54m
Annual income statement for Physiomics, fiscal year end - June 30th, GBP millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.799 | 0.702 | 0.83 | 0.597 | 0.543 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 0.933 | 1.04 | 1.19 | 1.17 | 1.21 |
| Operating Profit | -0.134 | -0.337 | -0.359 | -0.574 | -0.671 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.134 | -0.337 | -0.359 | -0.572 | -0.669 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.064 | -0.216 | -0.253 | -0.477 | -0.609 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.064 | -0.216 | -0.253 | -0.477 | -0.609 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.064 | -0.216 | -0.253 | -0.477 | -0.609 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.001 | -0.002 | -0.003 | -0.005 | -0.004 |